Dexcom reaffirms full-year forecast after topping quarterly estimates

0
135
Medical device maker Dexcom on Thursday reiterated its full-year revenue forecast after beating Wall Street estimates for ​quarterly results, helped by strong demand for its continuous glucose monitors ‌that track blood sugar levels.

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here